In cancer, STAT3 has been implicated in EGF-mediated EMT in ovarian cancer cell lines and STAT1 has been reported to inhibit angiogenesis in murine fibrosarcoma tumor cells [16]. This evidence concerns the gene STAT3 and ovarian carcinoma.